Neurotrials Research

Atlanta, Georgia 30342-1743

3 studies enrolling now · 21 studies all time

What they study most

Atrial Fibrillation, Cardiac Disease, Cataplexy Narcolepsy, Chronic Shift Work Sleep Disorder, Cognitive Impairment, Diabete Mellitus, Driving Impaired, Dyslipidemias, Episodic Migraine, Excessive Daytime Sleepiness, Familial Alzheimer Disease, Hypertension

Studies at this site

• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy — Recruiting now
• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy — Recruiting now
• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea — Completed
• Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) — Completed
• Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS — Completed
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy — Completed
• DELPHI in Subjects at Risk for Stroke and Dementia — Completed
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• Driving Simulation to Assess Non-Sedative Effects of Tolperisone — Completed
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
• Non-Inferiority Study of the FRESCA Airbox Positive Airway Pressure System — Completed
• Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL — Completed
• Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness — Completed